MedPath

海南中玉药业有限公司

Ownership
-
Established
2006-01-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

感冒清胶囊

Approval Number
国药准字Z46020095
Approval Date
Jul 24, 2024
NMPA

消炎利胆片

Approval Number
国药准字Z46020098
Approval Date
Jul 24, 2024
NMPA

夏桑菊颗粒

Approval Number
国药准字Z46020097
Approval Date
Jul 24, 2024
NMPA

消癌平咀嚼片

Approval Number
国药准字Z20090080
Approval Date
Jul 24, 2023
NMPA

Tenofovir Disoproxil Fumarate Tablets

Product Name
富马酸替诺福韦二吡呋酯片
Approval Number
国药准字H20233294
Approval Date
Mar 21, 2023
NMPA

Telmisartan

Product Name
替米沙坦
Approval Number
国药准字H20070245
Approval Date
Dec 9, 2022
NMPA

Tenofovir Disoproxil Fumarate

Product Name
富马酸替诺福韦二吡呋酯
Approval Number
国药准字H20173134
Approval Date
Nov 25, 2022
NMPA

Diclofenac Sodium and Lidocaine Hydrochloride for Injection

Product Name
注射用双氯芬酸钠利多卡因
Approval Number
国药准字H20120046
Approval Date
Apr 20, 2022
NMPA

Ozagrel Sodium for Injection

Product Name
注射用奥扎格雷钠
Approval Number
国药准字H20163135
Approval Date
Mar 12, 2021
NMPA

抗骨增生片

Approval Number
国药准字Z46020096
Approval Date
Jul 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.